April 10, 2018; 90 (15 Supplement) April 27, 2018
Autologous Haematopoietic Stem Cell Transplantation in Treatment Naïve Patients with Rapidly Evolving Severe Multiple Sclerosis (P6.350)
Joyutpal Das, John Snowden, Sona Mistry, Helen Jessop, Simon Bell, Basil Sharrack
First published April 9, 2018,
Joyutpal Das
1Department of Neuroscience, Royal Hallamshire Hospital Sheffield United Kingdom
John Snowden
2Department of Haematology, Royal Hallamshire Hospital Sheffield United Kingdom
3Department of Oncology & Metabolism, The University of Sheffield Sheffield United Kingdom
Sona Mistry
4Medical School, The University of Sheffield Sheffield United Kingdom
Helen Jessop
2Department of Haematology, Royal Hallamshire Hospital Sheffield United Kingdom
Simon Bell
5Sheffield Institute for Translational Neuroscience Sheffield United Kingdom
Basil Sharrack
1Department of Neuroscience, Royal Hallamshire Hospital Sheffield United Kingdom
5Sheffield Institute for Translational Neuroscience Sheffield United Kingdom
Autologous Haematopoietic Stem Cell Transplantation in Treatment Naïve Patients with Rapidly Evolving Severe Multiple Sclerosis (P6.350)
Joyutpal Das, John Snowden, Sona Mistry, Helen Jessop, Simon Bell, Basil Sharrack
Neurology Apr 2018, 90 (15 Supplement) P6.350;
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 90 no. 15 Supplement P6.350
Print ISSN:
Online ISSN:
History:
- First Published April 9, 2018.
Copyright & Usage:
© 2018
Author Disclosures
- 1Department of Neuroscience, Royal Hallamshire Hospital Sheffield United Kingdom
- 2Department of Haematology, Royal Hallamshire Hospital Sheffield United Kingdom
- 3Department of Oncology & Metabolism, The University of Sheffield Sheffield United Kingdom
- 4Medical School, The University of Sheffield Sheffield United Kingdom
- 5Sheffield Institute for Translational Neuroscience Sheffield United Kingdom
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.